Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics.
Carter BZ, Mak PY, Tao W, Ayoub E, Ostermann LB, Huang X, Loghavi S, Boettcher S, Nishida Y, Ruvolo V, Hughes PE, Morrow PK, Haferlach T, Kornblau S, Muftuoglu M, Andreeff M.
Carter BZ, et al. Among authors: ruvolo v.
Blood Cancer J. 2023 Apr 24;13(1):57. doi: 10.1038/s41408-023-00830-w.
Blood Cancer J. 2023.
PMID: 37088806
Free PMC article.